title: Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania.
abstract: BACKGROUND
  Antibiotic resistance is one of the most serious public health concerns worldwide and is increasing at an alarming rate, making daily treatment decisions more challenging. This study is aimed at identifying local bacterial isolates and their antimicrobial susceptibility patterns to avoid irrational antibiotic use, especially in settings where unguided management occurs and febrile illnesses are predominant.
  
  
  METHODS
  A hospital-based prospective cross-sectional study was conducted from September 2011 to February 2012. Febrile children were serially recruited and demographic and clinical data were collected using a standardized data collection tool. A blood culture was performed and identification of the isolates was undertaken using in-house biochemical tests. Susceptibility to common antibiotics was investigated using the disc diffusion methods.
  
  
  RESULTS
  Of the 1081 children admitted during the study period, 317 (29.3%) met the inclusion criteria and were recruited, of whom 195 (61.5%) and 122 (38.5%) were male and female respectively. The median age was 18 months with an interquartile range of 9 to 36 months. Of the 317 children, 251 (79.2%) were below or equal to 36 months of age. The prevalence of bacteremia was 6.6%. A higher prevalence of bacteraemia was observed in children below 36 months than in those ≥ 36 months (7.5% vs. 3.0%, p = 0.001). Predictors of bacteraemia were an axillary temperature of >38.5 °C (OR =7, 95% CI = 2.2 - 14.8, p-value = 0.0001), a positive malaria slide (OR =5, 95% CI = 3.0 - 21.2, p-value = 0.0001) and a high neutrophils' count (OR =21 95% CI = 5.6 - 84, p-value = 0.0001). Escherichia coli and Klebsiella pneumoniae accounted for 7 (33.3%) and 6 (28.6%) of all the isolates respectively. Others gram-negatives bacteria were Citrobacter spp 2 (9.5%), Enterobacter spp 1 (4.25%), Pseudomonas spp 2 (9.5%), Proteus spp 1 (4.25%) and Salmonella spp 1 (4.25%). These isolates were highly resistant to ampicillin (95%), co-trimoxazole (90%), tetracycline (90%), gentamicin (80%), augmentin (80%), chloramphenicol (65%), ceftriaxone (35%), cefotaxime (35%) ciprofloxacin (30%), amikacin (30%), ceftazidime (25%) and norfloxacine (10%).
  
  
  CONCLUSIONS
  Multi-resistant gram-negative bacteria are the commonest cause of bacteremia in under-fives attending the Bugando Medical Centre, Mwanza, Tanzania. A high body temperature, a positive malaria slide and a high absolute neutrophils' count were all independent risk factors found to predict bacteremia. A higher mortality rate was observed in children with bacteraemia. Continuous epidemiological surveillance should be conducted so that a proper and effective antibiotics management can be instituted, especially in children with a high grade fever, a positive malaria slide and a high neutrophils' count.
authors: Alexandra
authors: A
authors: Christopher
authors: Stephen E
authors: SE
authors: Mshana
authors: Benson R
authors: BR
authors: Kidenya
authors: Aldofineh
authors: A
authors: Hokororo
authors: Domenica
authors: D
authors: Morona
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D002452:Cell Count; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D005334:Fever / Q000453:epidemiology / Q000382:microbiology; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D008288:Malaria / Q000175:diagnosis; D008297:Male; D009504:Neutrophils / Q000378:metabolism; D015995:Prevalence; D011446:Prospective Studies; D013636:Tanzania / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents
references: Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9
references: 16355321
references: Arch Pediatr Adolesc Med. 1998 Jul;152(7):624-8
references: 9667531
references: Ann Emerg Med. 1993 Jul;22(7):1198-210
references: 8517575
references: Ann Trop Paediatr. 1993;13(1):45-53
references: 7681645
references: QJM. 2004 Sep;97(9):591-7
references: 15317928
references: J Hosp Infect. 2006 Mar;62(3):333-7
references: 16377028
references: J Clin Microbiol. 2000 Aug;38(8):2994-7
references: 10921966
references: Clin Infect Dis. 2006 Apr 15;42 Suppl 4:S164-72
references: 16544267
references: BMC Pediatr. 2010 Jun 04;10:39
references: 20525358
references: PLoS One. 2009 Aug 13;4(8):e6621
references: 19675669
references: BMC Infect Dis. 2007 May 22;7:43
references: 17519011
references: South Med J. 1980 Jul;73(7):904-5
references: 6966825
references: BMJ. 2005 Apr 30;330(7498):995
references: 15797893
references: Pediatr Infect Dis J. 2000 Apr;19(4):312-8
references: 10783021
references: Lancet. 2005 Mar 26-Apr 1;365(9465):1147-52
references: 15794969
references: BMC Infect Dis. 2011 May 19;11:137
references: 21595963
references: Arch Public Health. 2012 Mar 16;70(1):4
references: 22958592
references: Arch Pediatr Adolesc Med. 2002 May;156(5):512-7
references: 11980559
references: J Antimicrob Chemother. 2003 Oct;52(4):591-7
references: 12972449
references: East Afr Med J. 2004 Jan;81(1):47-51
references: 15080516
references: Arch Pediatr Adolesc Med. 1999 Mar;153(3):261-6
references: 10086403
references: BMC Infect Dis. 2009 Feb 18;9:19
references: 19226452
references: BMJ. 1999 Jan 9;318(7176):86-91
references: 9880280
references: Pediatr Clin North Am. 1999 Dec;46(6):1073-109
references: 10629675
references: N Engl J Med. 2005 Jan 6;352(1):39-47
references: 15635111
references: J Infect Dis. 2007 Mar 15;195(6):895-904
references: 17299721
references: Lancet. 2001 Mar 24;357(9260):950-2
references: 11289365
references: Lancet. 2011 Oct 8;378(9799):1316-23
references: 21903251
references: J Antimicrob Chemother. 2000 Jun;45(6):881-5
references: 10837444
references: Afr Health Sci. 2006 Sep;6(3):151-4
references: 17140336
references: BMC Infect Dis. 2006 Nov 07;6:160
references: 17090299